Skip To Main Content
Brigida Barberio on Muck Rack

Brigida Barberio

As seen in: Color Research & Application, Nature, Wiley, Wiley Online Library, Gut Journal, MDPI, The Lancet, EClinicalMedicine, Gastroenterology, Physician's Weekly and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brigida

Contact Brigida, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity

|
By Brigida Barberio, Edoardo Savarino, C. Riggott
| Wiley Online Library Verified
Handling Editor: Richard Gearry B.Barberio and E. V.Savarino, “Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity,” Alimentary Pharmacology & Therapeutics (2026): 1–2, https://doi.org/10.1111/apt.70641.
Open in Who Shared Issue with article?

Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trials

|
By Mohammad Al Hayek, Alfredo J. Lucendo, Brigida Barberio
| EClinicalMedicine Verified
Methods We conducted the study in accordance with The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement, which provides a standard framework for reporting the methods and results of such studies.27 The PRISMA checklist for this network meta-analysis is provided in the eTable S6. The study protocol was registered prospectively with PROSPERO (CRD420251116179).
Open in Who Shared Issue with article?

Network Meta‐Analysis: Efficacy of Biological Therapies and Small Molecules as Maintenance Therapy in Ulcerative Colitis

|
By Brigida Barberio, David J. Gracie, Christopher Black, Alexander Ford
| Wiley Online Library Verified
1 Introduction Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory disease of the colon, characterised by periods of remission and relapse, leading to significant morbidity and impaired quality of life [1]. Effective long-term management of UC relies on maintaining remission to prevent complications such as colectomy [2], hospitalisation [3], or corticosteroid dependence [4], which are associated with increased risks of infections, osteoporosis and metabolic disorders.
Open in Who Shared Issue with article?
See all 27 articles